UIM
VRTX icon

USS Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

USS Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3M Buy
48,893
+1,765
+4% +$782K 0.09% 142
2026
Q1 		$21M Buy
47,128
+1,735
+4% +$809K 0.08% 131
2025
Q4 		$20.6M Buy
45,393
+1,294
+3% +$558K 0.1% 121
2025
Q3 		$17.3M Sell
44,099
-55
-0.1% -$23K 0.08% 139
2025
Q2 		$19.7M Sell
44,154
-237
-0.5% -$109K 0.12% 115
2025
Q1 		$21.5M Sell
44,391
-12
-0% -$5.59K 0.16% 97
2024
Q4 		$17.9M Sell
44,403
-2,996
-6% -$1.39M 0.12% 131
2024
Q3 		$22M Sell
47,399
-997
-2% -$479K 0.16% 108
2024
Q2 		$22.7M Buy
48,396
+978
+2% +$424K 0.18% 91
2024
Q1 		$19.8M Buy
47,418
+1,449
+3% +$613K 0.16% 111
2023
Q4 		$18.7M Sell
45,969
-6,620
-13% -$2.45M 0.17% 106
2023
Q3 		$18.3M Buy
52,589
+1,087
+2% +$380K 0.2% 102
2023
Q2 		$18.1M Buy
51,502
+563
+1% +$190K 0.21% 101
2023
Q1 		$16M Buy
50,939
+2,625
+5% +$787K 0.22% 99
2022
Q4 		$13.9M Hold
48,314
– – 0.2% 115
2022
Q3 		$14M Sell
48,314
-18,809
-28% -$5.41M 0.2% 107
2022
Q2 		$18.9M Sell
67,123
-3,197
-5% -$856K 0.19% 112
2022
Q1 		$18.4M Buy
70,320
+5,908
+9% +$1.4M 0.15% 143
2021
Q4 		$14.1M Hold
64,412
– – 0.11% 192
2021
Q3 		$11.7M Buy
64,412
+41,375
+180% +$8.08M 0.1% 210
2021
Q2 		$4.65M Hold
23,037
– – 0.04% 271
2021
Q1 		$4.95M Hold
23,037
– – 0.04% 245
2020
Q4 		$5.44M Hold
23,037
– – 0.05% 219
2020
Q3 		$6.26M Buy
23,037
+884
+4% +$244K 0.06% 183
2020
Q2 		$6.43M Buy
+22,153
New +$6.01M 0.07% 180

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

USS Investment Management's VRTX Position: Q2 2026 in Review

USS Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 3.7% in Q2 2026, buying an estimated $782K and bringing the position to 48,893 shares worth $24.3M. The position accounts for 0.09% of the portfolio, ranked #142.

USS Investment Management first reported a position in VRTX in Q2 2020 and has held it in 25 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • USS Investment Management held 48,893 shares of Vertex Pharmaceuticals worth $24.3M as of Q2 2026.
  • USS Investment Management bought 1,765 Vertex Pharmaceuticals shares in Q2 2026, an estimated $782K.
  • Vertex Pharmaceuticals made up 0.09% of USS Investment Management's portfolio in Q2 2026, its #142 holding.
  • USS Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.